9.17
price down icon5.07%   -0.49
pre-market  Pre-market:  9.29   0.12   +1.31%
loading

Cogent Biosciences Inc Stock (COGT) Latest News

pulisher
Feb 05, 2025

Analytical Overview: Cogent Biosciences Inc (COGT)’s Ratios Tell a Financial Story - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

A year in review: Cogent Biosciences Inc (COGT)’s performance in the last year - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - Knox Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.3%What's Next? - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Short Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Expands By 9.3% - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Cogent Biosciences to Participate in the Guggenheim Biotech Conference - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

Inside Cogent's Next Big Move: Key Presentation Set for Guggenheim Conference - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

How the (COGT) price action is used to our Advantage - Stock Traders Daily

Jan 30, 2025
pulisher
Jan 27, 2025

JPMorgan Chase & Co. Buys 5,720 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jan 27, 2025
pulisher
Jan 25, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2%Here's Why - MarketBeat

Jan 25, 2025
pulisher
Jan 24, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Up 7.3%Still a Buy? - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by SG Americas Securities LLC - MarketBeat

Jan 24, 2025
pulisher
Jan 22, 2025

Assenagon Asset Management S.A. Sells 133,515 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jan 22, 2025
pulisher
Jan 20, 2025

Cogent and ModivCare gain after insider purchases - MSN

Jan 20, 2025
pulisher
Jan 19, 2025

How to Take Advantage of moves in (COGT) - Stock Traders Daily

Jan 19, 2025
pulisher
Jan 19, 2025

Cogent Biosciences Appoints James P. Geygan as Independent Director - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

Hennion & Walsh Asset Management Inc. Buys 103,293 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data - Seeking Alpha

Jan 18, 2025
pulisher
Jan 17, 2025

This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - Yahoo Finance

Jan 17, 2025
pulisher
Jan 17, 2025

Cole Pinnow Bought 2,085% More Shares In Cogent Biosciences - Yahoo Finance

Jan 17, 2025
pulisher
Jan 17, 2025

HC Wainwright Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $14.00 - Defense World

Jan 17, 2025
pulisher
Jan 17, 2025

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Price Target at $14.83 - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Cogent Biosciences chief commercial officer buys $332,412 in stock By Investing.com - Investing.com Canada

Jan 15, 2025
pulisher
Jan 15, 2025

Cogent stock ModivCare stock up on insider buys (COGT:NASDAQ) - Seeking Alpha

Jan 15, 2025
pulisher
Jan 15, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Gap UpHere's What Happened - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Cogent Biosciences chief commercial officer buys $332,412 in stock - Investing.com

Jan 15, 2025
pulisher
Jan 14, 2025

HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.83 Average Target Price from Analysts - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Cogent Biosciences (NASDAQ:COGT) Receives Neutral Rating from Wedbush - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Wedbush Reiterates Neutral Rating for Cogent Biosciences (NASDAQ:COGT) - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 11.9%Here's Why - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Cogent Biosciences Announces Planned 2025 Milestones for - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

Cogent Biosciences sets key 2025 milestones for drug trials By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

Cogent Biosciences sets key 2025 milestones for drug trials - Investing.com India

Jan 13, 2025
pulisher
Jan 13, 2025

Cogent Biosciences Sets Major 2025 Milestones: Three Phase 3 Results, First NDA Submission Planned - StockTitan

Jan 13, 2025
pulisher
Jan 09, 2025

Objective long/short (COGT) Report - Stock Traders Daily

Jan 09, 2025
pulisher
Jan 08, 2025

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Cogent Biosciences CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 08, 2025
pulisher
Jan 06, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Up 8.8%Still a Buy? - MarketBeat

Jan 06, 2025
pulisher
Dec 31, 2024

Cogent Biosciences (NASDAQ:COGT) Trading Down 2.5%What's Next? - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Holdings Trimmed by Jane Street Group LLC - Defense World

Dec 30, 2024
pulisher
Dec 30, 2024

Jane Street Group LLC Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Dec 30, 2024
pulisher
Dec 29, 2024

(COGT) Investment Report - Stock Traders Daily

Dec 29, 2024
pulisher
Dec 28, 2024

Geode Capital Management LLC Buys 300,062 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Dec 28, 2024
pulisher
Dec 28, 2024

Geode Capital Management LLC Purchases 300,062 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Dec 28, 2024
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):